"Baker McKenzie Advises Keensight Capital on Acquisition of Majority Stake in Bedfont Scientific Ltd."

"Baker McKenzie advised Keensight Capital on the financing of its acquisition of a majority stake in Bedfont Scientific Ltd., a company specializing in non-invasive breath analysis medical devices. Keensight aims to leverage its expertise and resources to support Bedfont's growth, international expansion, and innovation in the MedTech and respiratory fields."

Baker McKenzie advised Keensight Capital on the financing aspects of its acquisition of a majority stake in Bedfont® Scientific Ltd., a company specializing in non-invasive breath analysis medical devices. The transaction involved Keensight Capital, a leading private equity manager focused on pan-European Growth Buyout investments, acquiring a majority stake in Bedfont to support its next stage of growth. Keensight aims to strengthen Bedfont’s position as a global leader in the breath analysis field by leveraging its expertise, international footprint, and resources to accelerate growth and international expansion, both organically and through acquisitions, while scaling innovation. The Baker McKenzie team was led by Banking & Finance Partner Nick O’Grady, with support from Senior Associate Lana Ahern, Associates Natalie Lawman and Sarah Hyland, and Trainee Ed Walters.

"Baker McKenzie Advises Keensight Capital on Acquisition of Majority Stake in Bedfont Scientific Ltd."

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads